Spanish Red Biotech Pipeline

Gilead Sciences

Magrolimab + chemotherapy/SG combinations

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Metastatic triple-negative breast cancer
Phase: 2Phase II in Spain, 1Phase I in Spain